Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 08:52 am Sale | 2024-12-31 | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,153,837 5.390% | -58,735 (-0.11%) | Filing History |
| 2025-01-27 3:54 pm Unchanged | 2024-12-31 | 13G | Eli Lilly and Company LLY | LILLY ENDOWMENT INC | 96,891,978 10.200% | 0 (Unchanged) | Filing History |
| 2024-11-14 7:00 pm Sale | 2024-09-30 | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,212,572 5.390% | -327,533 (-0.64%) | Filing History |
| 2024-10-23 5:17 pm Sale | 2024-09-30 | 13G | Eli Lilly and Company LLY | LILLY ENDOWMENT INC | 96,891,978 10.200% | -2,876,832 (-2.88%) | Filing History |
| 2024-02-13 5:04 pm Sale | 2023-12-29 | 13G | Eli Lilly and Company LLY | VANGUARD GROUP INC | 71,604,696 7.540% | -1,825,167 (-2.49%) | Filing History |
| 2024-02-09 09:26 am Sale | 2023-12-31 | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,540,105 5.430% | -289,768 (-0.56%) | Filing History |
| 2024-01-29 3:26 pm Sale | 2023-12-31 | 13G | Eli Lilly and Company LLY | BlackRock Inc. BLK | 64,376,027 6.800% | -1,091,766 (-1.67%) | Filing History |
| 2024-01-26 4:25 pm Sale | 2023-12-31 | 13G | Eli Lilly and Company LLY | LILLY ENDOWMENT INC | 99,768,810 10.510% | -3,180,000 (-3.09%) | Filing History |
| 2023-08-14 4:30 pm Purchase | 2023-08-11 | 13D | Sigilon Therapeutics, Inc. SGTX | ELI LILLY & Co LLY | 100 100.000% | 100 (New Position) | Filing History |
| 2023-07-07 4:33 pm Purchase | 2023-06-28 | 13D | Sigilon Therapeutics, Inc. SGTX | ELI LILLY & Co LLY | 1,008,830 40.300% | 797,719 (+377.87%) | Filing History |
| 2023-02-10 10:42 am Sale | 2022-12-31 | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,829,873 5.250% | -58,582 (-0.11%) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | Eli Lilly and Company LLY | VANGUARD GROUP INC | 73,429,863 7.730% | 4,168,109 (+6.02%) | Filing History |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Eli Lilly and Company LLY | BlackRock Inc. BLK | 65,467,793 6.900% | 1,590,770 (+2.49%) | Filing History |
| 2023-01-27 4:57 pm Unchanged | 2022-12-31 | 13G | Precision BioSciences, Inc. DTIL | ELI LILLY & Co LLY | 125,406 3.400% | 0 (Unchanged) | Filing History |
| 2023-01-27 4:41 pm Unchanged | 2022-12-31 | 13G | AC Immune SA ACIU | ELI LILLY & Co LLY | 3,615,328 4.300% | 0 (Unchanged) | Filing History |
| 2023-01-25 4:14 pm Sale | 2022-12-31 | 13G | Eli Lilly and Company LLY | LILLY ENDOWMENT INC | 102,948,810 10.830% | -4,515,000 (-4.20%) | Filing History |
| 2022-12-23 4:39 pm Purchase | 2022-12-21 | 13G | ProQR Therapeutics N.V. PRQR | ELI LILLY & Co LLY | 13,371,562 16.600% | 9,381,586 (+235.13%) | Filing History |
| 2022-12-01 4:11 pm Sale | 2022-11-30 | 13D | Akouos, Inc. AKUS | ELI LILLY & Co LLY | 100 100.000% | -9,639,089 (-100.00%) | Filing History |
| 2022-10-27 4:31 pm Purchase | 2022-10-17 | 13D | Akouos, Inc. AKUS | ELI LILLY & Co LLY | 9,639,189 25.500% | 9,639,189 (New Position) | Filing History |
| 2022-02-11 07:46 am Sale | 2021-12-31 | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,888,455 5.420% | -123,696 (-0.24%) | Filing History |